Aster DM Healthcare Increases Stake in Prerana Hospitals to 98.92%
Aster DM Healthcare acquired an additional 11.94% stake in Prerana Hospitals Limited on December 30, 2025, increasing its total holding to 98.92%. The remaining 1.08% is expected to be acquired by December 31, 2026. The acquisition cost was ₹38.36 crore.
The acquisition of a significant stake in a subsidiary is strategically important but does not represent a major diversification or a very large financial outlay relative to the company's overall size.
The company is increasing its stake in a subsidiary, moving towards full ownership, which is generally a positive development for consolidation and control.
Aster DM Healthcare Limited has announced an update regarding its acquisition of the balance stake in Prerana Hospital Limited. Further to its disclosure on November 26, 2024, the company has acquired an additional 11.94% of the paid-up share capital of Prerana Hospitals Limited on December 30, 2025. This acquisition increases Aster DM Healthcare's shareholding from 87% to 98.92%. The remaining 1.08% is expected to be acquired by December 31, 2026.
Prerana Hospital Limited, a healthcare entity incorporated on December 03, 1996, is located in Kolhapur. Its turnover for FY 2024-25 was ₹145.05 crore, FY 2023-24 was ₹120.56 crore, and FY 2022-23 was ₹98.92 crore. The paid-up capital of Prerana Hospital Limited is ₹4,13,97,000. The acquisition, which has a cash consideration, was at a cost of ₹38.36 crore. This transaction is not classified as a related party transaction, and post-acquisition, Prerana Hospital Limited will become a wholly-owned subsidiary of Aster DM Healthcare Limited.
No governmental or regulatory approvals are required for this acquisition.
What to do with a filing like this
Aster DM Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aster DM Healthcare Limited. Read the original for the full detail.